Access to emergency contraception

The introduction of emergency contraception (EC) has encountered barriers derived from the erroneous perception of EC as an abortificient and conservative attitudes. In several countries, "prolife" groups have initiated lawsuits against national regulatory bodies for approving EC. Other barriers are limited availability and high price of dedicated products, lack of information among providers about EC and the requirement of medical prescription for EC. The availability of EC has increased in the last years due to efforts of multiple stakeholders. Facilitating factors include the acceptability of EC by users and providers; dissemination of information about EC; advocacy among policymakers; training of providers; registration of dedicated products; over the counter sates and inclusion of EC in the national norms. By 2005, 109 countries have registered around 50 dedicated products that are available in public services, pharmacies, NGOs or through social marketing and 45 countries have included EC in their national norms. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.